What is Humacyte Inc?
, together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 123.73M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 110,000 shares $6k |
| 3-6months | 0 | 240,000 shares $25k |
| 6-9months | 291,774 shares $82k | 267,818 shares $60k |
| 9-12months | 0 | 0 |